SLIT2 and acute myeloid leukemia: Previously, our study reported that hypermethylation of the SLIT2 promoter was associated with disease progression in myelodysplastic syndrome (MDS) and predicted poor clinical outcome in both MDS and acute myeloid leukemia (AML) [12].